Role of tumour-associated macrophages in cancer-related inflammation

Experimental Oncology

Volumn 32, Issue 3, 2010, Pages 153-158

  Sica, A ^a,b  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Cancer related inflammation; Tumor associated macrophages

Indexed keywords

ADAPTIVE IMMUNITY; ANGIOGENESIS; CANCER GROWTH; INFLAMMATION; INNATE IMMUNITY; METASTASIS; REVIEW; SOLID TUMOR; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT;

ANIMALS; HUMANS; INFLAMMATION; MACROPHAGES; NEOPLASMS;

EID: 77957735624     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature 2008; 454: 436-44.
2. Mantovani A. Cancer: inflamming metastasis. Nature 2009, 457: 36-7.
3. Sica A, Larghi P, Mancino A, et al. Macrophage polarization in tumour progression. Semin Cancer Biol 2008; 18: 349-55.
4. Mantovani A, Sozzani S, Locati M, et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002; 23: 549-55. (Pubitemid 35223554)
5. Kim S, Takahashi H, Lin W-W, et al. Carcinoma produced factors activate myeloid cells via TLR2 to stimulate metastasis. Nature 2009; 457: 102-6.
6. Kaplan RN, Riba RD, Zacharoulis S, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005; 438: 820-7. (Pubitemid 41753060)
7. Erler JT, Bennewith KL, Cox TR, et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 2009; 15: 35-44.
8. Mantovani A, Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol 2010; 22: 231-7.
9. Fridlender ZG, Sun J, Kim S, et al. Polarization of tumorassociated neutrophil (TAN) phenotype by TGF-beta: «N1» versus «N2» TAN - a new paradigm? Cancer Cell 2009; 16: 183-94.
10. Saccani A, Schioppa T, Porta C, et al. p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res 2006, 66: 11432-40. (Pubitemid 46009975)
11. Sica A, Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest 2007, 117: 1155-66. (Pubitemid 46718400)
12. DeNardo DG, Andreu P, Coussens LM. Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity. Cancer Metastasis Rev 2010; 29: 309-16.
13. Sinha P, Clements VK, Bunt SK, et al. Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J Immunol 2007, 179: 977-83.
14. de Visser KE, Korets LV, Coussens LM. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 2005, 7: 411-23.
15. Mantovani A. Cancer: inflammation by remote control. Nature 2005, 435: 752-3.
16. DeNardo DG, Barreto JB, Andreu P, et al. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 2009; 16: 91-102.
17. Andreu P, Johansson M, Affara NI, et al. FcRgamma activation regulates inflammation-associated squamous carcinogenesis. Cancer Cell 2010; 17: 121-34.
18. Wong SC, Puaux AL, Chittezhath M, et al. Macrophage polarization to a unique phenotype driven by B cells. Eur J Immunol 2009; 182: 6494-507.
19. Biswas SK, Gangi L, Paul S, et al. A distinct and unique transcriptional programme expressed by tumor-associated macrophages: defective NF-kB and enhanced IRF-3/STAT1 activation. Blood 2006; 107: 2112-22. (Pubitemid 43289397)
20. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006; 441: 431-436. (Pubitemid 44050137)
21. Hagemann T, Lawrence T, McNeish I, et al. «Reeducating » tumor-associated macrophages by targeting NF-kappaB. J Exp Med 2008; 205: 1261-8.
22. Porta C, Rimoldi M, Raes G, et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc Natl Acad Sci U S A 2009; 106: 14978-83.
23. Mantovani A, Sica A, Sozzani S, et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25: 677-86. (Pubitemid 39457982)
24. Murdoch C, Muthana M, Coffelt SB, et al. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 2008; 8: 618-31.
25. Rius J, Guma M, Schachtrup C, et al. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 2008; 453: 807-11. (Pubitemid 351793778)
26. Apetoh L, Ghiringhelli F, Tesniere A, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007; 13: 1050-9. (Pubitemid 47517504)
27. Pollard JW. Trophic macrophages in development and disease. Nat Rev Immunol 2009; 9: 259-70.
28. Kortylewski M, Kujawski M, Wang T, et al. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat Med 2005; 11: 1314-21. (Pubitemid 41752912)